Skip to Content

    Enterprise software company ­Veeva has become an indispensable nucleus for the life sciences industry, helping Big Pharma manage customer databases, track drug developments, and organize clinical trials. Revenues rose by 33% last year to $544 million, as the likes of Abbott, Merck, and Pfizer employed a suite of its cloud-based offerings. Vault, its new content management system, is already being used by 35 of the top 50 pharma companies. The platform could help Veeva take a bigger chunk of the global life sciences applications market, forecast to reach $6.8 billion in sales by 2020.

    41319CFF-E47E-4BA5-B1B8-ECA4D480B0DFCreated with sketchtool.62900797-6A09-46DF-8323-A45758A81292Created with sketchtool.Looking for leads, investment insights, or competitive intelligence?Buy Now

    Company Information

    Overall Score4.5
    Sector
    Technology
    Industry
    Computer Software
    CEO
    Peter P. Gassner
    Websitehttp://www.veeva.com
    Employees1,794
    HQ Location
    Pleasanton, Calif.
    Revenues ($M) (Past 12 Months)$617
    Profits ($M) (Past 12 Months)$117
    Market Value as of Oct. 9, 2017 ($M)$8,170